By Lewis Krauskopf (Reuters) - U.S. stocks climbed on Monday after a raft of manufacturing data globally and strength in healthcare shares following more acquisition activity. ..
The price for the long-anticipated deal was higher than many had expected, but ended a period of strategic uncertainty that had dogged Visa in recent months. Visa Inc and Visa ..
Influential short-selling firm Citron Research did not publish new allegations against Valeant Pharmaceuticals International Inc (VRX.TO) on Monday as many investors had antic ..
U.S. factory activity grew last month at its slowest pace since May 2013 as manufacturers pared their stockpiles and cut jobs. The Institute for Supply Management said Monday ..
The U.S. economy is on track to grow 1.9 percent in the fourth quarter with expected weaker consumer spending and equipment investment growth following a private report on U.S ..
Quebec is sure that its $1 billion lifeline for Bombardier Inc (BBDb.TO) will not result in any trade disputes triggered by concerns from the train and plane maker's riva ..
HONG KONG/LONDON (Reuters) - HSBC profit jumped by a third in the latest quarter as a drop in fines for past misconduct more than offset the impact of a slowdown in Asia and i ..
Shire Plc (SHP.L) has agreed to buy U.S. rare disease specialist Dyax Corp (DYAX.O) for about $5.9 billion - and potentially up to $6.5 billion - while still pursuing a five t ..
Investment banks Guggenheim Partners LLC and JPMorgan Chase & Co have secured key roles in Pfizer Inc's merger negotiations with Allergan Plc , according to people fa ..
U.S. manufacturing activity in October hit a 2-1/2-year low, but a rise in new orders offered hope for a sector buffeted by a strong dollar and relentless spending cuts by ene ..
| Top Brokers | ||
|---|---|---|
| #1 |  |
|
| #2 |  |
|
| #3 |  |
|
| #4 |  |
|
| #5 |  |
|
Risk Disclosure: fxBrokerSearch.com will not be held liable for any financial loss or damage caused by users acting upon any information contained within this website, not limited to and including: all numerical data, quotes, charts and buy/sell signals. Moreover, please be advised that Forex trading is one of the most volatile investment forms in the world and all trades should be placed with full consideration of the risks and costs.
fxBrokerSearch.com does not support nor encourage the execution of any investments. Trading with a margin is high risk endeavour and not suitable for everyone, therefore, each investor should carefully consider all relevant trading conditions, such as experience, risk and cost, before taking part in any type of trading, including Forex.
While every effort has been made to ensure all our data is as accurate as possible, fxBrokerSearch.com cannot be held responsible for any prices that are not in line with real-time data. Indeed, the currency exchange market is constantly changing and all CFDs (stocks, indexes, futures) and Forex prices are set by market makers.
This means advertised prices may not be accurate and could differ from the actual market conditions. For this reason it is not appropriate to rely on any data presented by fxBrokerSearch.com for the purposes of trading.
Based on these conditions, fxBrokerSearch.com will not be held responsible for any losses incurred through trades conducted in light of data presented on this site.
